PMID- 21077957 OWN - NLM STAT- MEDLINE DCOM- 20120522 LR - 20111213 IS - 1399-0012 (Electronic) IS - 0902-0063 (Linking) VI - 25 IP - 6 DP - 2011 Nov-Dec TI - Kidney transplant performed after liver transplant: a single center experience. PG - 915-20 LID - 10.1111/j.1399-0012.2010.01369.x [doi] AB - Changes in liver allocation due to institution of the model for end-stage liver disease/PELD criteria have led to an increase in the number of patients receiving liver transplants who have elevated creatinine. Whether these patients' renal dysfunction is reversible or not and whether they should receive combined liver and kidney transplants (KTXs) are individualized decisions, although some criteria are becoming clearer. A part of this decision must consider the outcomes of patients who have liver transplants alone but later require KTXs. We herein describe our single-center experience with this patient population. Our data show that KTX subsequent to liver transplantation (TX) is generally safe and effective, with a possibly higher surgical complication rate than standard KTX. Outcomes analysis showed not statistically different patient survival of KTXs performed after liver transplant (KALT) compared with KTX alone. Death censored graft survival was statistically lower in the KALT group but this largely accrued in the first three yr after transplant and was nearly equivalent by 10 yr. CI - (c) 2010 John Wiley & Sons A/S. FAU - Levine, Matthew H AU - Levine MH AD - Division of Transplant Surgery, Department of Surgery, University of Pennsylvania, Philadelphia, PA 19104, USA. matthew.h.levine@uphs.upenn.edu FAU - Parekh, Justin AU - Parekh J FAU - Feng, Sandy AU - Feng S FAU - Freise, Chris AU - Freise C LA - eng GR - 234-2005-370011C/PHS HHS/United States PT - Clinical Trial PT - Journal Article PT - Research Support, Non-U.S. Gov't PT - Research Support, U.S. Gov't, P.H.S. DEP - 20101116 PL - Denmark TA - Clin Transplant JT - Clinical transplantation JID - 8710240 SB - IM MH - Adult MH - Child MH - End Stage Liver Disease/*therapy MH - Female MH - Follow-Up Studies MH - Graft Rejection/*prevention & control MH - Humans MH - Kidney Diseases/*therapy MH - Kidney Transplantation/*mortality MH - Liver Transplantation/*mortality MH - Male MH - Middle Aged MH - Retrospective Studies MH - Survival Rate MH - Treatment Outcome MH - Young Adult EDAT- 2010/11/17 06:00 MHDA- 2012/05/23 06:00 CRDT- 2010/11/17 06:00 PHST- 2010/11/17 06:00 [entrez] PHST- 2010/11/17 06:00 [pubmed] PHST- 2012/05/23 06:00 [medline] AID - 10.1111/j.1399-0012.2010.01369.x [doi] PST - ppublish SO - Clin Transplant. 2011 Nov-Dec;25(6):915-20. doi: 10.1111/j.1399-0012.2010.01369.x. Epub 2010 Nov 16.